← Leaderboards
Cynthia M Carlsson
University Of Wisconsin Madison
$8,045,616
Attributed
$8,045,616
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,045,616 · 9
VA$0 · 1
By mechanism
P30$5,420,228 · 2
R01$1,646,636 · 1
K23$884,833 · 2
M01$93,919 · 4
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- William E Fahl$1,406,498
- Richard J Chappell$5,256,093
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposCerebrospinal FluidMiddle AgeS DiseaseMagnetic Resonance ImagingCognitivePharmaceutical PreparationsAdultBrainWisconsinPre-ClinicalS Disease RiskNeuroimagingCohortAmyloidBiological MarkersBlood VesselsParticipantTau ProteinsPreventRecording Of Previous EventsImpaired CognitionFundingPlacebos
Grant awards (30)
Core B - Clinical Core$1,023,489
P30 · FY2025 · AG · contact PI
Core B - Clinical Core$1,030,472
P30 · FY2024 · AG · contact PI
Impact of Icosapent Ethyl on Alzheimers Disease Biomarkers in Preclinical Adults$0
I01 · FY2024 · VA · contact PI
Clinical Core$476,405
P30 · FY2023 · AG · contact PI
Impact of Icosapent Ethyl on Alzheimers Disease Biomarkers in Preclinical Adults$0
I01 · FY2023 · VA · contact PI
Clinical Core$628,462
P30 · FY2022 · AG · contact PI
Impact of Icosapent Ethyl on Alzheimers Disease Biomarkers in Preclinical Adults$0
I01 · FY2022 · VA · contact PI
Clinical Core$1,239,814
P30 · FY2021 · AG · contact PI
Impact of Icosapent Ethyl on Alzheimers Disease Biomarkers in Preclinical Adults$0
I01 · FY2021 · VA · contact PI
Clinical Core$547,224
P30 · FY2020 · AG · contact PI
Impact of Icosapent Ethyl on Alzheimers Disease Biomarkers in Preclinical Adults$0
I01 · FY2020 · VA · contact PI
Clinical Core$474,362
P30 · FY2019 · AG · contact PI
Impact of Icosapent Ethyl on Alzheimers Disease Biomarkers in Preclinical Adults$0
I01 · FY2019 · VA · contact PI
Impact of Icosapent Ethyl on Alzheimers Disease Biomarkers in Preclinical Adults$0
I01 · FY2018 · VA · contact PI
Impact of Icosapent Ethyl on Alzheimers Disease Biomarkers in Preclinical Adults$0
I01 · FY2017 · VA · contact PI
Impact of Icosapent Ethyl on Alzheimers Disease Biomarkers in Preclinical Adults$0
I01 · FY2016 · VA · contact PI
Statin Effects on Beta-Amyloid and Cerebral Perfusion in Adults at Risk for AD$145,000
R01 · FY2013 · AG · contact PI
Statin Effects on Beta-Amyloid and Cerebral Perfusion in Adults at Risk for AD$489,569
R01 · FY2011 · AG · contact PI
Statin Effects on Beta-Amyloid and Cerebral Perfusion in Adults at Risk for AD$483,628
R01 · FY2010 · AG · contact PI
Statin Effects on Beta-Amyloid and Cerebral Perfusion in Adults at Risk for AD$528,439
R01 · FY2009 · AG · contact PI
Effect of Statins on Pathobiology of Alzheimer's Disease$194,377
K23 · FY2008 · AG · contact PI
Effect of Statins on Pathobiology of Alzheimer's Disease$190,862
K23 · FY2007 · AG · contact PI
EFFECT OF STATINS ON THE PATHOBIOLOGY OF ALZHEIMER'S DISEASE: THE ESPRIT TRIAL$4,366
M01 · FY2007 · RR · contact PI
IMPACT OF ATORVASTATIN ON CEREBRAL PERFUSION AND ENDOTHELIAL FUNCTION$1,021
M01 · FY2007 · RR · contact PI
Effect of Statins on Pathobiology of Alzheimer's Disease$186,043
K23 · FY2006 · AG · contact PI
EFFECT OF STATINS ON THE PATHOBIOLOGY OF ALZHEIMER'S DISEASE: THE ESPRIT TRIAL$36,305
M01 · FY2006 · RR · contact PI
Effect of Statins on Pathobiology of Alzheimer's Disease$184,718
K23 · FY2005 · AG
EFFECTS OF SIMVASTATIN ON THE PATHOBIOLOGY OF ALZHEIMER'S DISEASE: PAST STUDY$32,584
M01 · FY2005 · RR
Effect of Statins on Pathobiology of Alzheimer's Disease$128,833
K23 · FY2004 · AG
Effects of Simvastatin on the Pathobiology of Alzheimer's Disease: PAST Study$19,643
M01 · FY2004 · RR